Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value: $1.391B (91.1% shares, 8.9% debt)

Holdings (19)

VTI VANGUARD INDEX FDS 22.9%
Value $319M Shares 2,979,100 Est. Cost $57.39 Unrealized
OPHTHOTECH CORP 18.4%
Value $256M Shares 4,910,487 Est. Cost $32.35 Unrealized
INGN INOGEN INC 11.4%
Value $158M Shares 3,549,320 Est. Cost $17.78 Unrealized +115.8%
WRIGHT MEDICAL GROUP 8.9%
Value $124M Shares 4,720,065 Est. Cost $2.50 Unrealized
VGK VANGUARD INTL EQUITY INDEX F 8.2%
Value $113M Shares 2,101,000 Est. Cost $45.01 Unrealized
ALDER BIOPHARMACEUTICALS INC 7.4%
Value $103M Shares 1,951,183 Est. Cost $20.07 Unrealized
NEVRO CORP 5.9%
Value $82.01M Shares 1,525,704 Est. Cost $38.67 Unrealized
FLEXION THERAPEUTICS INC 3.4%
Value $46.69M Shares 2,133,131 Est. Cost $17.27 Unrealized
TOBIRA THERAPEUTICS INC 3.3%
Value $46.51M Shares 2,696,405 Est. Cost $17.25 Unrealized
ADAPY ADAPTIMMUNE THERAPEUTICS PLC 2.3%
Value $32.29M Shares 1,761,567 Est. Cost $18.33 Unrealized
COLUCID PHARMACEUTICALS INC 2.0%
Value $27.2M Shares 3,056,563 Est. Cost $8.90 Unrealized
OTONOMY INC 1.4%
Value $20.12M Shares 875,025 Est. Cost $24.00 Unrealized
TOKAI PHARMACEUTICALS INC 1.2%
Value $16.47M Shares 1,238,252 Est. Cost $14.41 Unrealized
AKBA AKEBIA THERAPEUTICS INC 1.1%
Value $15.6M Shares 1,516,387 Est. Cost $24.08 Unrealized -64.6%
HTG MOLECULAR DIAGNOSTICS INC 1.0%
Value $14.27M Shares 1,280,185 Est. Cost $11.15 Unrealized
INVUITY INC 0.8%
Value $10.46M Shares 740,616 Est. Cost $14.12 Unrealized
GKOS GLAUKOS CORP 0.2%
Value $2.174M Shares 75,000 Est. Cost $29.05 Unrealized 0.0%
AERIE PHARMACEUTICALS INC 0.1%
Value $1.765M Shares 100,000 Est. Cost $29.19 Unrealized
XENE XENON PHARMACEUTICALS INC 0.1%
Value $1.471M Shares 127,563 Est. Cost $14.68 Unrealized -5.8%